Death Rate Due to COVID-19 in Alzheimer's Disease and Frontotemporal Dementia.
Age Factors
Aged
Aged, 80 and over
Alzheimer Disease
/ complications
COVID-19
Coronavirus Infections
/ complications
Female
Frontotemporal Dementia
/ complications
Humans
Hypertension
/ complications
Independent Living
Male
Nursing Homes
Pandemics
Pneumonia, Viral
/ complications
Prevalence
Risk Factors
Alzheimer’s disease
COVID-19
SARS-CoV-2
care homes
frontotemporal dementia
Journal
Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863
Informations de publication
Date de publication:
2020
2020
Historique:
pubmed:
20
10
2020
medline:
26
11
2020
entrez:
19
10
2020
Statut:
ppublish
Résumé
We aimed to evaluate the frequency and mortality of COVID-19 in patients with Alzheimer's disease (AD) and frontotemporal dementia (FTD). We conducted an observational case series. We enrolled 204 patients, 15.2% of whom were diagnosed with COVID-19, and 41.9% of patients with the infection died. Patients with AD were older than patients with FTD (80.36±8.77 versus 72.00±8.35 years old) and had a higher prevalence of arterial hypertension (55.8% versus 26.3%). COVID-19 occurred in 7.3% of patients living at home, but 72.0% of those living at care homes. Living in care facilities and diagnosis of AD were independently associated with a higher probability of death. We found that living in care homes is the most relevant factor for an increased risk of COVID-19 infection and death, with AD patients exhibiting a higher risk than those with FTD.
Identifiants
pubmed: 33074240
pii: JAD200940
doi: 10.3233/JAD-200940
doi:
Types de publication
Letter
Observational Study
Langues
eng
Sous-ensembles de citation
IM